Category: Uncategorized

Streetwise Live! – Algernon Pharmaceuticals CEO Christopher Moreau and Dr. David Nutt Discuss Phase 1 DMT Study For Stroke
Proactive Investors Interview – Algernon Pharmaceuticals Phase 2 Human Study of Ifenprodil for IPF and Chronic Cough is Now 70% Enrolled
Stockhouse – Algernon Pharmaceuticals Makes Major Headway Toward Clinical Trials for Treatment of Stroke
Proactive Investors Interview – Algernon Pharmaceuticals Launches Ifenprodil Pancreatic Cancer Clinical Research Program
Weekend Dispensary – Could the ‘spirit molecule’ be a treatment option for stroke?
Psychedelic Finance – Interview with Dr. Rick Strassman | DMT Stroke Program Consultant, Algernon Pharmaceuticals
Algernon Pharmaceutical’s DMT Clinical Research Program for Stroke Receives Positive FDA Feedback
PRMediaNow Algernon Pharmaceuticals Update with CEO Christopher Moreau
Proactive Interview regarding 50% enrollment into the IPF/Chronic Cough
Psychedelic Finance – Interview with Professor David Nutt | Algernon Pharmaceuticals DMT Stroke Consultant

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.